Medicines Management Optimisation Achieving your 5 a day post-mi Medication WORKSHOP
|
|
- Beryl McKenzie
- 5 years ago
- Views:
Transcription
1 Medicines Management Optimisation Achieving your 5 a day post-mi Medication WORKSHOP
2 What is Medicines Optimisation? the safe and effective use of medicines to enable the best possible outcomes NICE ng
3 What do BACPR S&CC say? Cardioprotective Medication Current use of cardioprotective medication should be assessed (inc adherence) with the aim of ensuring uptitration of medication during the programme so that evidence-based dosages are achieved. Patients beliefs about medication should also be assessed as this affects adherence to drug regimens Key drugs: antiplatelets, lipid-lowering, betablockers, ACE-I/AIIRA, calcium channel blockers, anticoagulants, diuretics
4 What do CC for HBC&E say? Recognise opportunities and barriers to implementing interventions Agree goals for the intervention Implement behaviour change in a manner consistent with its underlying philosophy Make and review action plans based on identified goals Carry out health behaviour problem solving End the intervention in a planned manner and to plan for long term maintenance of the new health behaviours
5 What about non-medical prescribing? Aims: Medicine access patient choice increased more efficient and quicker Improve access to advice & services; Good use of appropriately skilled & placed healthcare workforce Includes allowing doctors to make best use of their expertise Contribute to an integrated seamless healthcare system; Increase capacity to meet the increased demand for the provision of new and existing NHS services; Improve patient care without compromising patient safety
6 Medicines Optimisation achieving 5-a-day as part of cardiac rehabilitation 0. General post-mi 1. Single / dual antiplatelet therapy 2. ACE-I / AIIRA 3. Statin 4. Betablocker 5. GTN 5. PPI
7
8 0. General post-mi medication
9 0. General post-mi medication Reduced morbidity & mortality Reduce progression of disease (CHD. ACS. HF) Keenness to follow instructions High contact with CR for modifications, answers, info Address misconceptions Fit with lifestyle Instil ownership History & Examination Usual effects & s.effects of medications vs those of post-mi Effective system for your team & area Negotiation, communication, listening, pt-centred skills Guidelines Newness forgetting medication, lack of fit Wellness need not felt Side-effects of medication vs s.effects of post-mi Ownership. Whose job is it? Time for assessment, review, up-titration, follow-up Access to notes System safe, effective, individualised, aspirational CR play its part in the bigger picture: pt. relative. GP. PN. Cardiologist. Pharmacist. Daily News. Others Role of self Education & information opportunities
10 1. Anti-platelet: single / dual
11 1. Anti-platelet: single / dual Reduce platelet aggregation DAPT for time-limited period Bruising Bleeding Upper GI symptoms BD forgetfulness Misunderstanding of need for both synergistic effect Past gastric ulceration/issue, bleeding hx, age, anaemia. AF Surgery Anticoagulant Abdominal tenderness Aspirin: with or without water; with food Communicate length of therapy Doors and windows - DAPT Guidelines?
12 2. ACE-I / AIIRB
13 2. ACE-I / AIIRB Prevent HF. Reduced morbidity & mortality Re-introduction post revascularisation Up-titration. Down-titration Monitoring Sx, U&E, BP Symptomatic low BP Cough Angioedema. Renal failure. Bilateral RAS Ownership over titrations Past intolerance cough, angioedema, bilateral RAS Renal function Diuretics. Potassium supplementation Hypertension. HF U&E 7 days post up-titration Guidelines? Planned what to do if; monitoring; holidays Shared care GP, PN, Cardiologist, CR team nonprescribers, PATIENT Communication
14 3. Statin
15 3. Statin Reduce mortality and morbidity Improve the numbers lower LDL & cholesterol (when to test?) Reduce vascular inflammation, stabilise plaque Up-titrate. Down-titrate. Switch Past intolerance really? Alcohol excess Liver function test Familial hyperlipidaemia. Simon Broom criteria Lipid levels Guidelines? Simvastatin circadian rhythm forgetfulness Myopathy vs new exercise effect Keeping up with the latest news My cholesterol is normal Establishing on suitable, effective drug & dose Cost? Monitoring muscular aches CK after 2 day exercise-free symptomic only With exercise (HDL), weight loss, healthy eating Familial hypercholesterolaema nurse
16 4. Betablocker
17 4. Betablocker Up to 1 year post MI Reduce symptoms in HF Improve survival Up-titration. Down-titration. De-prescribing Timing Wheeze. Tiredness. Cold peripheries. ED. Mood Bradycardia. Heart block. Asthma 5 day dip post up-titration Reduced hypoglycaemia warning Chest conditions. Intolerance. Pulmonary oedema. Unstable HF Hypertension. Angina Guidelines? Planned what to do if; monitoring; holidays Shared care GP, PN, Cardiologist, CR team nonprescribers, PATIENT Communication
18 5. Nitrolingual spray
19 5. Nitrolingual spray Peripheral vasodilatation Increase confidence Reduce fear Reduce unnecessary re-admission Prophylaxis when pattern established Join with what to do if advice Past use. Associations of past use at MI ED & use of PDE5 inhibitors Trial in your clinic? Guidelines? Headaches. Hypotension Dyspepsia vs angina vs MSK vs anxiety Fear of use inevitable admission fear Embarrassment. Family concern Taste associated with effectiveness PDE5 inhibitors Avoid scare-induction Panic! I ve forgotten my spray Review if new or increased need for spray
20 5. PPI
21 5. PPI Prophylaxis in view if DAPT plus Reduce unnecessary re-admissions with CP Encourage best time of day empty stomach Appropriate referral for review Up-titration. Down-titration. De-prescribing Weight loss. Healthy eating. Alcohol & nicotine reduction or cessation Past tolerance and intolerance Chest and abdo exam & palpation Anaemia Guidelines? Gastric upset try another Not all fit with Clopidogrel Head and Shoulders effect Systemic effect of Aspirin & DAPT Start as in-pt CR review & alter or refer GP Information
22 Considerations for achieving 5 a day My role in medication optimisation As non-medical prescriber in CR As non-prescriber in CR Systems in place or not in place How I fit into the bigger team with patient, family, community pharmacist, GP, practice nurse, cardiologist; working together How can I and my team alter my / our / the system so it fits? A good start Improving my/our role with one medication Use resources team, guidelines made easy, web, forums, associations Audit results & share to improve care; NMC revalidation
23
24 go forth & optimise Any questions or comments?
CARDIAC REHABILITATION PROGRAMME:- MEDICATION
CARDIAC REHABILITATION PROGRAMME:- MEDICATION AIM OF THIS SESSION Understand the reasons for taking your medications, Discuss the common side effects associated with these medications - knowing when to
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1
More informationType 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.
Type 2 Diabetes Stopping Smoking Consider referral to smoking cessation BMI > 25 kg m² Set a weight loss target of a 5-10% reduction Consider referring for weight management advice Control BP to
More informationNES Asthma Hospital Medication Care Plan 7
NES Asthma Hospital Medication Care Plan 7 PATIENT DETAILS Name Liz Duncan Address Consultant Gender Female Weight 60kg Height 1.6m General Practitioner Dr Jones Community Pharmacist Date of Birth (Age)
More informationIschaemic Heart Disease
Ischaemic Heart Disease Katherine Rothwell Case 1 65 yr old female PMHx : Eczema, is a smoker 20/day Comes to see you complaining of central chest pain Present past few months. Comes on when gardening
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu Indicator area: Pulse rhythm assessment for AF Indicator: NM146 Date: June 2017 Introduction There is evidence
More informationCardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
More informationGuidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010
Guidelines to assist General Practitioners in the Management of Type 2 Diabetes April 2010 Foreword The guidelines were devised by the Diabetes Day Centre in Beaumont Hospital in consultation with a number
More informationVolume 2; Number 11 July 2008
Volume 2; Number 11 July 2008 CONTENTS Page 1 NICE Clinical Guideline 67: Lipid Modification (May 2008) Page 7 NICE Technology Appraisal 132: Ezetimibe for the treatment of primary (heterozygous familial
More informationRoyal Wolverhampton Hospital Adult Lipid Lowering Therapy Guidelines Lipid Lowering Therapy for the Prevention of Cardiovascular Disease
Royal Wolverhampton Hospital Adult Lipid Lowering Therapy Guidelines 1 This guideline is intended to assist rational and cost-effective prescribing of lipid regulating medications across both primary and
More informationCoronary Heart Disease and Stroke, Primary and Secondary Prevention Guidelines (Cholesterol)
CLINICAL GUIDELINE Coronary Heart Disease and Stroke, Primary and Secondary Prevention Guidelines (Cholesterol) A guideline is intended to assist healthcare professionals in the choice of disease-specific
More informationChronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update)
Chronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update) NICE guideline Apendix C The algorithms Draft for consultation, January 2010 Chronic
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationCardiovascular risk reduction in diabetes Lipids (NICE CG181)
Cardiovascular risk reduction in diabetes Lipids (NICE CG181) Primary Prevention T1DM Offer Atorvastatin 20mg if >40 years old Diabetes duration >10 years Established nephropathy Other CVS risk factors
More informationCONCISE GUIDE National Clinical Guidelines for Stroke 2nd Edition
CONCISE GUIDE 2004 National for Stroke 2nd Edition This concise guide summarises the recommendations, graded according to the evidence, from the National 2nd edition. As critical aspects of care are not
More informationPREVENTIVE AND REHABILITATIVE MANAGEMENT OF ACUTE CORONARY SYNDROMES (NSTEMI, STEMI, PCI)
PREVENTIVE AND REHABILITATIVE MANAGEMENT OF ACUTE CORONARY SYNDROMES (NSTEMI, STEMI, PCI) Dato Dr. Balachandran Kandasamy Institut Jantung Negara 12 th November 2016 KEY MESSAGES 1. Initiate a long-term
More informationStroke secondary prevention. Gill Cluckie Stroke Nurse Consultant St. George s Hospital
Stroke secondary prevention Gill Cluckie Stroke Nurse Consultant St. George s Hospital Stroke recurrence The risk of recurrent stroke is greatest after first stroke 2 3% of survivors of a first stroke
More informationCORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW
CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6. Coronary Artery Disease (CAD): Antiplatelet
More informationNICE QIPP about Lipitor. Robert Trotter. Clinical Effectiveness Consultant
NICE QIPP about Lipitor Robert Trotter Clinical Effectiveness Consultant LIP2894c Date of preparation: April 2009 Prescribing information for atorvastatin is available on the last slide Roadmap Background
More informationMedications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.
Medications Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. What do I need to know about medications after my heart attack? When you
More informationProgram Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.
More informationNurse Prescribing in Cardiology. Jan Keenan Consultant Nurse; NMP Lead
Nurse Prescribing in Cardiology Jan Keenan Consultant Nurse; NMP Lead Jan.keenan@ouh.nhs.uk Objectives Nurse prescribing for cardiology: where are we now? What are nurses prescribing in cardiology? The
More informationPractice-Level Executive Summary Report
PINNACLE Registry Metrics 0003, Test Practice_NextGen [Rolling: 1st April 2015 to 31st March 2016 ] Generated on 5/11/2016 11:37:35 AM American College of Cardiology Foundation National Cardiovascular
More informationIndigestion (dyspepsia)
Commissioning pathways Indigestion (dyspepsia) Supplementary information to be read in conjunction with the pathway Reference Supplementary Information 1.1 Symptom Description Annual incidence 40%. Prevalence
More information1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown
Medical-Surgical Nursing Care Second Edition Karen Burke Priscilla LeMone Elaine Mohn-Brown Chapter 26 Caring for Clients with Coronary Heart Disease and Dysrhythmias Coronary Heart Disease (CHD) Leading
More informationRapid access chest pain clinic (RACPC)
Rapid access chest pain clinic (RACPC) Context Coronary heart disease (CHD) remains the common cause of death and premture death in the UK with 15% of men and 7% of women dying from the disease. UK death
More information1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare?
1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare? Dr Nerys Davies, GPST Ms B. Davies, Specialist Nurse (Heart Failure) Dr J. Taylor, Consultant Cardiologist
More informationLipid Lowering in patients with High Risk of Cardiovascular Disease (Primary Prevention)
Lipid Lowering in patients with High Risk of Cardiovascular Disease (Primary Prevention) Policy Statement: October 2010 This policy defines the decision made by NHS Wirral following an evidence review
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
More informationClinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126
Stable angina: management Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationNew indicators to be added to the NICE menu for the QOF and amendments to existing indicators
New indicators to be added to the for the QOF and amendments to existing indicators 1 st September 2015 Version 1.1 This document was originally published on 3 rd August 2015, it has since been updated.
More informationWhat is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital
What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital What is a myocardial infarction? THEY AINT WHAT THEY USED TO BE Case
More informationQOF Indicator DM013:
QOF Indicator DM013: The percentage of patients with diabetes, on the register, who have a record of a dietary review by a suitably competent professional in the preceding 12 months Note: the bold signposts
More informationAPPENDIX 2F Management of Cholesterol
Patients with established CVD: Coronary heart disease Cerebrovascular disease Peripheral vascular disease APPEDIX 2F Management of Cholesterol Patients at high risk of cardiovascular events: Chronic kidney
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Peripheral arterial disease Potential output:
More informationInverclyde CHP Protected Learning Event- Heart Failure
Inverclyde CHP Protected Learning Event- Heart Failure 14:00 14:05 14:05 14:20 14:20 14:30 14:30 15:10 15:10 15:30 15:30 15:50 15:50 16:05 16:05 16:35 Welcome & Introduction Paul Forsyth (HF Pharmacist)
More informationAdvanced Heart Failure Management. Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary
Advanced Heart Failure Management Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary Grading of heart failure Mr WY age 73 3/12 dyspnoea, fatigue and some ankle oedema PMH: hypertension
More informationCommissioning for value focus pack
Commissioning for value focus pack Clinical commissioning group: NHS MILTON KEYNES CCG Focus area: Cardiovascular disease (CVD) pathway Version 2 June 2014 Contents 1. Background and context About the
More informationAcute Coronary Syndromes: Challenges to Management. Claire Williams November 2017
Acute Coronary Syndromes: Challenges to Management Claire Williams November 2017 Challenge 1: Diagnosis Chest pain >20 minutes ECG Challenge 1: Diagnosis Treat as STEMI Chest pain >20 minutes ECG STEMI
More informationComplications of Diabetes mellitus. Dr Bill Young 16 March 2015
Complications of Diabetes mellitus Dr Bill Young 16 March 2015 Complications of diabetes Multi-organ involvement 2 The extent of diabetes complications At diagnosis as many as 50% of patients may have
More informationCV Update Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet 27/01/09
CV Update Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet 27/01/09 Dr Ameet Bakhai, FRCP Cardiologist, Clinical Trials, Health Economics Barnet & Chase Farm NHS Trust Royal Free
More informationReview guidance for patients on long-term amiodarone treatment
Review guidance for patients on long-term amiodarone treatment This review guidance document has been produced in response to: 1. Current supply shortages of branded and generic versions of 100mg and 200mg
More informationAtrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency
Atrial Fibrillation A guide for Southwark General Practice Key Messages 1. Routinely offer pulse checks to patients at high risk of AF 2. Use the CHA 2 DS 2 VASc score to identify patients for anticoagulation
More informationFlolan. Potent pulmonary and systemic vasodilator Three major potential pharmacologic actions
1995 FDA approved for PAH - NYHA functional class III/IV 2000 - FDA for SPH r/t scleroderma and related disorders 2000 Medicare expanded coverage: cardiac d/o, portal htn, SPH r/t congenital disorders
More informationChest Pain. Dr Robert Huggett Consultant Cardiologist
Chest Pain Dr Robert Huggett Consultant Cardiologist Outline Diagnosis of cardiac chest pain 2016 NICE update on stable chest pain Assessment of unstable chest pain/acs and MI definition Scope of the
More informationLong-Term Management Of the ACS Patient: State-of-the-Art. Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA
Long-Term Management Of the ACS Patient: State-of-the-Art Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA Disclosures I have no disclosures. Case Study 45 y/o male admitted to
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationPreventive Cardiology Scientific evidence
Preventive Cardiology Scientific evidence Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College London Primary prevention
More informationLong-Term Complications of Diabetes Mellitus Macrovascular Complication
Long-Term Complications of Diabetes Mellitus Macrovascular Complication Sung Hee Choi MD, PhD Professor, Seoul National University College of Medicine, SNUBH, Bundang Hospital Diabetes = CVD equivalent
More informationProof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government
Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...
More informationCase study Chest Pain treating angina without a bypass or stent
Case study Chest Pain treating angina without a bypass or stent Dr Clare Hawley Associate Specialist Cardiology Chesterfield Royal Hospital GPwSI for Angina Management Programme Hon Lecturer Cardiology
More information2010 ACLS Guidelines. Primary goals of therapy for patients
2010 ACLS Guidelines Part 10: Acute Coronary Syndrome Present : 內科 R1 鍾伯欣 Supervisor: F1 吳亮廷 991110 Primary goals of therapy for patients of ACS Reduce the amount of myocardial necrosis that occurs in
More informationPrimary Prevention of Stroke
Primary Prevention of Stroke Dr Chris Ellis Cardiologist Green Lane CVS Service, Auckland City Hospital & Auckland Heart Group, Mercy Hospital, Auckland 67 Pages Long, 735 References 29 Sub-Headings for
More informationSteps Against Recurrent Stroke (STARS)
Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life. Your Guide to Ischemic What happened to me? You had a stroke. The stroke you had
More informationMedicine Dr. Omed Lecture 2 Stable and Unstable Angina
Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel
More informationHeart Failure (HF) - Primary Care Flow Charts. Pre diagnosis Symptoms or signs suggestive of HF
Heart Failure (HF) - Primary Care Flow Charts Pre diagnosis Symptoms or signs suggestive of HF 12 lead ECG Normal examination and 12 lead ECG HF highly unlikely Abnormal 12 lead ECG HF Possible Arrange
More informationHeart Failure (HF) - Primary Care Flow Charts. Symptoms or signs suggestive of HF. Pre diagnosis. Refer to the Heart Failure Clinic at VHK for
Heart Failure (HF) - Primary Care Flow Charts Pre diagnosis Symptoms or signs suggestive of HF 12 lead ECG Normal examination and 12 lead ECG HF highly unlikely Abnormal 12 lead ECG HF Possible Arrange
More informationMPharmProgramme. Hypertension (HTN)
MPharmProgramme Hypertension (HTN) Slide 1 of 30 Overview Definition Prevalence Type Causes Diagnosis Management Patients perspective Slide 2 of 30 Definition It is not a disease! So what is it? What two
More informationReducing risk in heart disease
Reducing risk in heart disease An expert guide to clinical practice for secondary prevention of coronary heart disease Prof Patricia Davidson (chair) Prof Nigel Stocks Dr Anu Aggarwal Ms Jill Waddell Ms
More informationMRCP(UK) PACES. INFORMATION FOR THE CANDIDATE Training Scenario N 001 SAMPLE HOST CENTRE Station 5: BRIEF CLINICAL CONSULTATION
INFORMATION FOR THE CANDIDATE MRCP(UK) PACES Station 5: BRIEF CLINICAL CONSULTATION Patient details: Mrs XX aged 45. Your role: You are the doctor in the medical admissions unit. You have 10 minutes with
More informationChapter 2 - Cardiovascular System. Primary Care Prescribing Formulary - Preferred Drug Choices
Chapter 2 - Cardiovascular System Primary Care Prescribing Formulary - Preferred Drug Choices Drug group Drug choice Comments/notes Cardiac glycosides Thiazide diuretics Loop diuretics Aldosterone antagonist
More informationGuidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee
Guidelines for the Management of Dyspepsia and GORD Document type: Version: 3.0 Author (name): Author (designation): Validated by Prescribing Dr. G. Lipscomb Date validated October 2015 Ratified by: Date
More informationBelinda Green, Cardiologist, SDHB, 2016
Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens
More informationSIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence
SIGN 149 Risk estimation and the prevention of cardiovascular disease Quick Reference Guide July 2017 Evidence ESTIMATING CARDIOVASCULAR RISK R Individuals with the following risk factors should be considered
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME. Indicator Assessment Report
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Output: Advice for NHS England Assessment Report Date of QOF Advisory Committee meeting:
More informationRepeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group
Repeat ischaemic heart disease audit of primary care patients (2002-2003): Comparisons by age, sex and ethnic group Baseline-repeat ischaemic heart disease audit of primary care patients: a comparison
More informationThis information explains the advice about the care and treatment of people with stable angina that is set out in NICE clinical guideline 126.
Information for the public Published: 1 July 2011 nice.org.uk About this information NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and the treatments
More informationABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour
ABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour Dr Indranil Dasgupta Rationale No national practical
More informationPreventing Cardiovascular Disease Stroke Primary Prevention Guidelines. John Potter Professor Ageing & Stroke Medicine University of East Anglia
Preventing Cardiovascular Disease Stroke Primary Prevention Guidelines John Potter Professor Ageing & Stroke Medicine University of East Anglia Preventing Cardiovascular Disease Stroke Primary Prevention
More information5.2 Key priorities for implementation
5.2 Key priorities for implementation From the full set of recommendations, the GDG selected ten key priorities for implementation. The criteria used for selecting these recommendations are listed in detail
More information1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11
May 2011 1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11 Yes b) If confirmed please provide details on the number of
More informationIdentification and management of familial hypercholesterolaemia (FH) - An overview
Identification and management of familial hypercholesterolaemia (FH) - An overview National Collaborating Centre for Primary Care and Royal College of General Practitioners NICE Guideline CG 71 (August
More informationCardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention
Cardiology Self Learning Package Module 5: Pharmacology: Treatment of Acute Coronary Syndromes, Module 5: Pharmacology: Hyperlipidaemia, Treatment of Acute Coronary Hypertension, Symdrome, Hyperlipidaemia,
More informationFrimley Health Area Prescribing Committee
Frimley Health Area Prescribing Committee Frimley Health NHS Foundation Trust North East Hampshire and Farnham CCG East Berkshire CCG Surrey Heath CCG Buckinghamshire CCG SHARED CARE Guideline Amber Traffic
More informationCoronary Artery Disease
Coronary Artery Disease This information is at http://www.nhlbi.nih.gov/health/dci/diseases/cad/cad_all.html and is provided by the NHLBI, one of the Institutes of the National Institutes of Health. To
More informationCardiac Rehabilitation after Primary Coronary Intervention CONTRA
DEBATE SESSION Is there a role for cardiac rehabilitation in the modern era of Percutaneous coronary intervention and coronary artery bypass grafting? Cardiac Rehabilitation after Primary Coronary Intervention
More informationOverview. NOT A REPETION OF LOCAL GUIDELINE Dr Diviash Thakrar
Overview 1. Why hypertension is important? 2. What are basic principles in treatment? 3. Different ways of measuring 4. Hypercholesterolemia NOT A REPETION OF LOCAL GUIDELINE CVD risk factors? Non modifiable
More informationDr Joan Leighton. Professor Gerry Devlin. 14:00-14:55 WS #106: Whats Topical in Cardiology 15:05-16:00 WS #116: Whats Topical in Cardiology (Repeated)
Professor Gerry Devlin Clinical Cardiologist and Interventional Cardiologist NZ Heart Foundation Hamilton Dr Joan Leighton General Practitioner Heart Foundation Christchurch 14:00-14:55 WS #106: Whats
More informationSheffield guidelines for the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017)
Sheffield guidelines f the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017) Approved by Sheffield Area Prescribing Committee and Sheffield Teaching Hospitals
More informationWhat s new in Cardiovascular medicine? Dr Stephen Dorman Consultant Cardiologist, Morriston Cardiac Centre Mid & West Cardiac Network Lead
What s new in Cardiovascular medicine? Dr Stephen Dorman Consultant Cardiologist, Morriston Cardiac Centre Mid & West Cardiac Network Lead A year in review... Primary & sceondary Prevention IHD & Coronary
More informationPrimary Prevention Patients aged 85yrs and over
Rotherham Guideline for the management of Non-Familial Hypercholesterolaemia Type 1 Diabetes Offer lifestyle advice Over 40yrs of age? Diabetic for more than 10 years? Established nephropathy? Other CVD
More informationMyAction Couple: Primary Prevention Case Study. Teresa Mackay, Rhian Houghton, Tim Grove
MyAction Couple: Primary Prevention Case Study Teresa Mackay, Rhian Houghton, Tim Grove Reason for Referral and Patient Demographics Referral Mr Smith Referred by GP High CVD 34.5% QRISK Hypertension (155/92)
More informationTeresa Neal. Pippa Travers-Mason. Aboriginal Health Worker. Consultant clinical pharmacist MPH, Med, BPharm AACPA
Teresa Neal Aboriginal Health Worker Pippa Travers-Mason Consultant clinical pharmacist MPH, Med, BPharm AACPA WHERE Burden of disease So what do we do stats To date: Started October 2012 770 ish reviews
More informationCKD and risk management : NICE guideline
CKD and risk management : NICE guideline 2008-2014 Shahed Ahmed Consultant Nephrologist shahed.ahmed@rlbuht.nhs.uk Key points : Changing parameters of CKD and NICE guidance CKD and age related change of
More informationMedications and your Heart. RBCH Foundation Trust
Medications and your Heart RBCH Foundation Trust Today I will try and cover Confusing cocktail of drugs? What are they for? How do I take them? What if I forget to take them? What are common side effects?
More informationVolume 2; Number 14 September 2008 NICE CLINICAL GUIDELINE 66: TYPE 2 DIABETES THE MANAGEMENT OF TYPE 2 DIABETES (MAY 2008)
Volume 2; Number 14 September 2008 NICE CLINICAL GUIDELINE 66: TYPE 2 DIABETES THE MANAGEMENT OF TYPE 2 DIABETES (MAY 2008) The purpose of this special edition of the PACE Bulletin is to summarize the
More informationInitial assessment of patient with AF in primary care DR BRUCE TAYLOR GPwSI Cardiology SCN Merseyside and Cheshire Clinical Lead Primary care
Initial assessment of patient with AF in primary care DR BRUCE TAYLOR GPwSI Cardiology SCN Merseyside and Cheshire Clinical Lead Primary care 11 th and 25 th September 2014 3 KEY OBJECTIVES OF TALK 1.
More informationCardiovascular Pharmacotherapy
Cardiovascular Pharmacotherapy Overview Mechanism of cardiovascular drugs Indications and clinical use in cardiology Renin-Angiotensin Inhibitors: Angiotensin-Converting Enzyme Inhibitors, Angiotensin
More informationArrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist
Arrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist LOTS!!! This presentation confines itself to the situation in the North West. The views expressed are my
More informationManagement of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018
Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management
More informationAdherence to health behaviour advice in heart failure
Adherence to health behaviour advice in heart failure Prof. Nana Pogosova National Research Center for Preventive Medicine Moscow, Russian Federation Heart Failure (HF) As the final point for many cardiac
More informationHypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg
Hypertension diagnosis (see detail document) Non-diabetic Diabetic Very elderly (older than 80 years) Target less than 140/90mmHg Target less than 130/80mmHg Consider SBP target less than 150mmHg Non-diabetic
More informationKnow the Quality of our Care at Every Step. Kansas City ACS Summit BI-State Cardiovascular Education Consortium
Know the Quality of our Care at Every Step Kansas City ACS Summit BI-State Cardiovascular Education Consortium Welcome to the Kansas City ACS Summit Objectives: Follow the flow and care of an ACS patient
More informationPerformance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set
Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer
More informationPharmaceutical Care of People with Atrial Fibrillation. Course information
Pharmaceutical Care of People with Atrial Fibrillation Course information Pharmaceutical Care of People with Atrial Fibrillation Course information page 3 Introduction 5 Teaching plan 6 Needs Assessment
More informationCoronary Heart Disease. Iqbal Malik
Coronary Heart Disease Iqbal Malik Pathophysiology IHD Case chest pain Question -interactive What is the result of the exercise test? 1. negative 2. positive 3. equivocal 4. other Q2 answer STEMI! What
More informationE-portfolio guide. This guide will take you through, step by step, the type of information we expect you to record at each stage of your cycle.
E-portfolio guide The e-portfolio is designed to help you become a reflective learner and to emphasise the knowledge you are picking up on a daily basis. This guide will take you through, step by step,
More informationHelen Williams Consultant Pharmacist for CV Disease - South London
Helen Williams Consultant Pharmacist for CV Disease - South London CVD remains the leading cause of death in the UK Accounts for a third of all deaths 46,000 deaths in people < 75 years (70% of these
More informationGASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA
GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA MANAGEMENT Dyspepsia refers to a spectrum of usually intermittent upper gastrointestinal symptoms, including epigastric pain and heartburn. For the majority
More informationACE. Inhibitors. Quiz feedback
ACE Inhibitors Quiz feedback bpac nz better medicin e bpac nz Quiz feedback, ACE inhibitors, 2006 Best Practice Advocacy Centre ACE inhibitors quiz feedback bpac nz Development Team: Rachael Clarke Sonia
More information